Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study. IJPRMH [Internet]. 2025 Sep. 26 [cited 2026 Apr. 19];1(1):10-9. Available from: https://ijprmh.com/journal/index.php/ijprmh/article/view/4